UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043963
Receipt number R000046465
Scientific Title An exploratory study on the association between squamous cell carcinoma occurrence and upper gastrointestinal microbiota in patients with laryngopharyngeal cancer
Date of disclosure of the study information 2021/04/18
Last modified on 2023/04/20 12:57:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An exploratory study on the association between squamous cell carcinoma occurrence and upper gastrointestinal microbiota in patients with laryngopharyngeal cancer

Acronym

An exploratory study on the association between squamous cell carcinoma occurrence and upper gastrointestinal microbiota in patients with laryngopharyngeal cancer

Scientific Title

An exploratory study on the association between squamous cell carcinoma occurrence and upper gastrointestinal microbiota in patients with laryngopharyngeal cancer

Scientific Title:Acronym

An exploratory study on the association between squamous cell carcinoma occurrence and upper gastrointestinal microbiota in patients with laryngopharyngeal cancer

Region

Japan


Condition

Condition

Laryngopharyngeal cancer

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

To compare the microbial profiles between the patients with laryngopharyngeal cancer and healthy subjects

Basic objectives2

Others

Basic objectives -Others

To elucidate pathophysiology

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Microbial profile between the patients with laryngopharyngeal cancer and healthy subjects
1) Relative abundance at the level of phylum/genus/OTU level
2) Alfa-diversity [Shannon index, Chao1 index, ACE, Number of observed OTUs]
3) Beta-diversity [weighted and unweighted UniFrac distance-based analysis]

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients with a current or past history of laryngopharyngeal cancer and healthy subjects

Key exclusion criteria

1.Patients whom the principal investigator determined to be inappropriate to participate in the study
2. Patients under the age of 20
3. Patients who are pregnant
4. Patients who underwent antibiotic treatment within a month
5. Patients who took proton pump inhibitors within a month

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Yuko
Middle name
Last name Hara

Organization

The Jikei University School of Medicine

Division name

Department of Endoscopy

Zip code

105-8471

Address

3-19-18, Nishishinbashi, Minato-ku, Tokyo

TEL

0334331111

Email

yukohara0526@gmail.com


Public contact

Name of contact person

1st name Yuko
Middle name
Last name Hara

Organization

The Jikei University School of Medicine

Division name

Department of Endoscopy

Zip code

105-8471

Address

3-19-18, Nishishinbashi, Minato-ku, Tokyo

TEL

0334331111

Homepage URL


Email

yukohara0526@yahoo.co.jp


Sponsor or person

Institute

The Jikei University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Own resources

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

RIKEN

Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Jikei University School of Medicine

Address

Department of Endoscopy

Tel

0334331111

Email

yukohara0526@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 04 Month 18 Day


Related information

URL releasing protocol

Testing ongoing

Publication of results

Unpublished


Result

URL related to results and publications

Testing ongoing

Number of participants that the trial has enrolled

10

Results

Testing ongoing

Results date posted

2023 Year 04 Month 20 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Testing ongoing

Participant flow

Testing ongoing

Adverse events

Testing ongoing

Outcome measures

Testing ongoing

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 03 Month 12 Day

Date of IRB

2020 Year 03 Month 12 Day

Anticipated trial start date

2020 Year 06 Month 06 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Not applicable


Management information

Registered date

2021 Year 04 Month 18 Day

Last modified on

2023 Year 04 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046465


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name